Published in J Clin Invest on May 01, 2003
Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Invest Ophthalmol Vis Sci (2011) 1.70
Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc Am Thorac Soc (2007) 1.65
Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Infect Dis (2004) 1.63
Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio (2015) 1.56
The role of the microbiome in exacerbations of chronic lung diseases. Lancet (2014) 1.55
Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa. Am J Respir Cell Mol Biol (2006) 1.45
The Microbiome and the Respiratory Tract. Annu Rev Physiol (2015) 1.35
Pulmonary surfactant: an immunological perspective. Cell Physiol Biochem (2009) 1.34
Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa. Infect Immun (2005) 1.29
Application of a neutral community model to assess structuring of the human lung microbiome. MBio (2015) 1.25
Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2007) 1.15
Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A. J Biol Chem (2010) 1.14
Clearance of Pseudomonas aeruginosa from a healthy ocular surface involves surfactant protein D and is compromised by bacterial elastase in a murine null-infection model. Infect Immun (2009) 1.14
Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species. Infect Immun (2004) 1.09
Recent advances in alveolar biology: evolution and function of alveolar proteins. Respir Physiol Neurobiol (2010) 1.08
The Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Disease. PLoS Pathog (2015) 1.07
Multifunctional role of human SPLUNC1 in Pseudomonas aeruginosa infection. Infect Immun (2012) 1.06
Innate host defense of the lung: effects of lung-lining fluid pH. Lung (2004) 1.05
Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT/enhancer binding proteins. J Immunol (2007) 1.04
Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury. Front Biosci (Landmark Ed) (2012) 1.04
Pulmonary surfactant: a front line of lung host defense. J Clin Invest (2003) 1.03
Comparative signature-tagged mutagenesis identifies Pseudomonas factors conferring resistance to the pulmonary collectin SP-A. PLoS Pathog (2005) 1.03
Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A. PLoS One (2011) 1.03
Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains. J Lipid Res (2009) 1.03
Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth. Infect Immun (2012) 1.02
Structural and functional differences among human surfactant proteins SP-A1, SP-A2 and co-expressed SP-A1/SP-A2: role of supratrimeric oligomerization. Biochem J (2007) 0.99
Interaction of SP-A (surfactant protein A) with bacterial rough lipopolysaccharide (Re-LPS), and effects of SP-A on the binding of Re-LPS to CD14 and LPS-binding protein. Biochem J (2005) 0.98
Role of defensins in corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Infect Immun (2010) 0.98
Klebsiella pneumoniae outer membrane protein A is required to prevent the activation of airway epithelial cells. J Biol Chem (2011) 0.98
Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D. Infect Immun (2005) 0.98
An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity. Front Immunol (2012) 0.98
Antimicrobial compounds in tears. Exp Eye Res (2013) 0.97
Collectins and cationic antimicrobial peptides of the respiratory epithelia. Vet Pathol (2006) 0.97
Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides. Antimicrob Agents Chemother (2008) 0.96
Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophages. J Biol Chem (2011) 0.95
Bordetella bronchiseptica adherence to cilia is mediated by multiple adhesin factors and blocked by surfactant protein A. Infect Immun (2005) 0.95
The flagellum of Pseudomonas aeruginosa is required for resistance to clearance by surfactant protein A. PLoS One (2007) 0.94
Staphylococcus aureus elicits marked alterations in the airway proteome during early pneumonia. Infect Immun (2008) 0.93
Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease. BMC Pulm Med (2010) 0.93
Recognition of bacterial surface polysaccharides by lectins of the innate immune system and its contribution to defense against infection: the case of pulmonary pathogens. Infect Immun (2007) 0.92
Transcriptional responses of Mycobacterium tuberculosis to lung surfactant. Microb Pathog (2009) 0.92
Pulmonary collectins protect macrophages against pore-forming activity of Legionella pneumophila and suppress its intracellular growth. J Biol Chem (2010) 0.90
Pulmonary collectins selectively permeabilize model bacterial membranes containing rough lipopolysaccharide. Biochemistry (2006) 0.89
Surfactant protein A forms extensive lattice-like structures on 1,2-dipalmitoylphosphatidylcholine/rough-lipopolysaccharide-mixed monolayers. Biophys J (2007) 0.89
Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities. Infect Immun (2004) 0.89
Macrophage immunoregulatory pathways in tuberculosis. Semin Immunol (2014) 0.88
SP-A permeabilizes lipopolysaccharide membranes by forming protein aggregates that extract lipids from the membrane. Biophys J (2008) 0.87
Purification, characterization and immunolocalization of porcine surfactant protein D. Immunology (2005) 0.86
The Pseudomonas aeruginosa flagellum confers resistance to pulmonary surfactant protein-A by impacting the production of exoproteases through quorum-sensing. Mol Microbiol (2011) 0.86
Surfactant-associated protein A provides critical immunoprotection in neonatal mice. Infect Immun (2007) 0.86
The microbiome and critical illness. Lancet Respir Med (2015) 0.85
Staphylococcus aureus and Pseudomonas aeruginosa express and secrete human surfactant proteins. PLoS One (2013) 0.84
Diverse functions of pulmonary collectins in host defense of the lung. J Biomed Biotechnol (2012) 0.84
The bacterial microbiota in inflammatory lung diseases. Clin Immunol (2015) 0.84
Noncapsulated Klebsiella pneumoniae bearing mannose-containing O antigens is rapidly eradicated from mouse lung and triggers cytokine production by macrophages following opsonization with surfactant protein D. Infect Immun (2005) 0.83
Pulmonary infections in swine induce altered porcine surfactant protein D expression and localization to dendritic cells in bronchial-associated lymphoid tissue. Immunology (2005) 0.82
Perinatal exposure to alcohol: implications for lung development and disease. Paediatr Respir Rev (2012) 0.82
The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections. Ann Am Thorac Soc (2015) 0.81
The Effect of Perfluorooctane Sulfonate, Exposure Time, and Chemical Mixtures on Methanogenic Community Structure and Function. Microbiol Insights (2015) 0.81
Surfactant protein D inhibits adherence of uropathogenic Escherichia coli to the bladder epithelial cells and the bacterium-induced cytotoxicity: a possible function in urinary tract. J Biol Chem (2012) 0.80
Donor surfactant protein D (SP-D) polymorphisms are associated with lung transplant outcome. Am J Transplant (2013) 0.79
Effects of airway surface liquid pH on host defense in cystic fibrosis. Int J Biochem Cell Biol (2014) 0.79
Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure. Respir Res (2009) 0.79
Restoration of lung surfactant protein D by IL-6 protects against secondary pneumonia following hemorrhagic shock. J Infect (2013) 0.79
Surfactant protein A binds flagellin enhancing phagocytosis and IL-1β production. PLoS One (2013) 0.79
Protective Role of Surfactant Protein D in Ocular Staphylococcus aureus Infection. PLoS One (2015) 0.79
Composition and Predicted Metabolic Capacity of Upper and Lower Airway Microbiota of Healthy Dogs in Relation to the Fecal Microbiota. PLoS One (2016) 0.79
The protective effects of Ambroxol in Pseudomonas aeruginosa-induced pneumonia in rats. Arch Med Sci (2011) 0.78
Regulation of surfactant protein D in the rodent prostate. Reprod Biol Endocrinol (2007) 0.78
Innate immunity of surfactant proteins A and D in urinary tract infection with uropathogenic Escherichia coli. Innate Immun (2015) 0.78
Genetic variants and monoallelic expression of surfactant protein-D in inflammatory bowel disease. Ann Hum Genet (2011) 0.78
Monocyte CD64 or CD89 targeting by surfactant protein D/anti-Fc receptor mediates bacterial uptake. Immunology (2006) 0.78
Assessment of surfactant protein A (SP-A) dependent agglutination. BMC Pulm Med (2010) 0.78
Type IV pilus of Pseudomonas aeruginosa confers resistance to antimicrobial activities of the pulmonary surfactant protein-A. J Innate Immun (2013) 0.78
Genetic complexity of the human surfactant-associated proteins SP-A1 and SP-A2. Gene (2012) 0.78
Neonatal mucosal immunology. Mucosal Immunol (2016) 0.77
Surfactant protein d deficiency in mice is associated with hyperphagia, altered fat deposition, insulin resistance, and increased basal endotoxemia. PLoS One (2012) 0.77
Surfactant protein D inhibits lipopolysaccharide-induced monocyte chemoattractant protein-1 expression in human renal tubular epithelial cells: implication for tubulointerstitial fibrosis. Clin Exp Immunol (2012) 0.77
Dipeptidyl peptidase I controls survival from Klebsiella pneumoniae lung infection by processing surfactant protein D. Biochem Biophys Res Commun (2014) 0.77
Surfactant protein D contributes to ocular defense against Pseudomonas aeruginosa in a murine model of dry eye disease. PLoS One (2013) 0.77
SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and Activation. PLoS One (2015) 0.76
Surfactant Protein D Binds to Coxiella burnetii and Results in a Decrease in Interactions with Murine Alveolar Macrophages. PLoS One (2015) 0.76
Type IV pilus glycosylation mediates resistance of Pseudomonas aeruginosa to opsonic activities of the pulmonary surfactant protein A. Infect Immun (2015) 0.76
Effect of nebulized bovine surfactant for experimental otitis media with effusion. Clin Exp Otorhinolaryngol (2010) 0.76
Surfactant Protein D modulates HIV infection of both T-cells and dendritic cells. PLoS One (2013) 0.76
C1q as an autocrine and paracrine regulator of cellular functions. Mol Immunol (2016) 0.75
Comparative evaluation of heterologous production systems for recombinant pulmonary surfactant protein D. Front Immunol (2014) 0.75
Keratinocyte growth factor supports pulmonary innate immune defense through maintenance of alveolar antimicrobial protein levels and macrophage function. Am J Physiol Lung Cell Mol Physiol (2016) 0.75
Increased surfactant protein D fails to improve bacterial clearance and inflammation in serpinB1-/- mice. Am J Respir Cell Mol Biol (2012) 0.75
Three distinct pneumotypes characterize the microbiome of the lung in BALB/cJ mice. PLoS One (2017) 0.75
Disruption of the structural and functional features of surfactant protein A by acrolein in cigarette smoke. Sci Rep (2017) 0.75
Structure, genetics and function of the pulmonary associated surfactant proteins A and D: The extra-pulmonary role of these C type lectins. Ann Anat (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene (1989) 23.74
Quorum sensing in bacteria. Annu Rev Microbiol (2001) 14.41
Innate immunity: the virtues of a nonclonal system of recognition. Cell (1997) 9.42
Phylogenetic perspectives in innate immunity. Science (1999) 9.42
Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest (1985) 8.63
The C-type lectin superfamily in the immune system. Immunol Rev (1998) 3.63
Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect Immun (1996) 3.53
LIVE/DEAD BacLight : application of a new rapid staining method for direct enumeration of viable and total bacteria in drinking water. J Microbiol Methods (1999) 3.01
Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol (2000) 2.55
Immunomodulatory functions of surfactant. Physiol Rev (1997) 2.48
Characterization studies on a new lectin found in seeds of Vicia ervilia. FEBS Lett (1975) 2.36
Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci U S A (1996) 2.29
Effects of a surfactant-associated protein and calcium ions on the structure and surface activity of lung surfactant lipids. Biochemistry (1985) 2.17
The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest (2002) 2.13
Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol (2000) 2.12
Mannose-binding proteins isolated from rat liver contain carbohydrate-recognition domains linked to collagenous tails. Complete primary structures and homology with pulmonary surfactant apoprotein. J Biol Chem (1986) 2.10
Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J Clin Invest (1992) 2.04
Isolation and characterization of the Escherichia coli htrB gene, whose product is essential for bacterial viability above 33 degrees C in rich media. J Bacteriol (1991) 2.02
Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol (2000) 1.95
Antimicrobial peptides of vertebrates. Curr Opin Immunol (1998) 1.94
Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol (1998) 1.92
Trimeric structure of a C-type mannose-binding protein. Structure (1994) 1.91
LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther (2002) 1.74
Collectins and pulmonary innate immunity. Immunol Rev (2000) 1.68
The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope. J Immunol (1984) 1.67
Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol (1999) 1.57
Collectins and pulmonary host defense. Am J Respir Cell Mol Biol (1998) 1.57
Surfactant protein A and surfactant protein D in health and disease. Am J Physiol (1998) 1.56
Adhesion of S-fimbriated Escherichia coli to brain glycolipids mediated by sfaA gene-encoded protein of S-fimbriae. J Biol Chem (1993) 1.55
Antimicrobial peptides of phagocytes and epithelia. Semin Hematol (1997) 1.50
Tissue distribution of surfactant proteins A and D in the mouse. J Histochem Cytochem (2002) 1.33
Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice. J Immunol (2000) 1.32
Crystal structure of the trimeric alpha-helical coiled-coil and the three lectin domains of human lung surfactant protein D. Structure (1999) 1.31
Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides. Biochem J (1994) 1.26
Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens. J Clin Invest (2001) 1.24
Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis. Infect Immun (2001) 1.24
Induction of intra- and extra-cellular phospholipids in the lungs of rats exposed to silica. Biochem J (1986) 1.23
Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J Immunol (1999) 1.23
Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells. J Biol Chem (1988) 1.22
Immunolocalization of surfactant protein-D (SP-D) in human fetal, newborn, and adult tissues. J Histochem Cytochem (2002) 1.20
Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am J Physiol (1996) 1.20
A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo. Eur J Immunol (1999) 1.16
Role of OmpA and IbeB in Escherichia coli K1 invasion of brain microvascular endothelial cells in vitro and in vivo. Pediatr Res (2002) 1.11
Primary structure of rat pulmonary surfactant protein D. cDNA and deduced amino acid sequence. J Biol Chem (1992) 1.08
Evaluation of methods for the quantitation of cysteines in proteins. Anal Biochem (1998) 1.06
Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice. Am J Physiol Lung Cell Mol Physiol (2000) 1.06
Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir Dis (1991) 1.05
Isolation and sequence of a cDNA clone for the rat pulmonary surfactant-associated protein (PSP-A). Biochem Biophys Res Commun (1987) 0.99
Calcium dependent association of surfactant protein A with pulmonary surfactant: application to simple surfactant protein A purification. Arch Biochem Biophys (1996) 0.98
Aggregation and opsonization of type A but not type B Hemophilus influenzae by surfactant protein A. Am J Respir Cell Mol Biol (1994) 0.97
Recombinant SP-D carbohydrate recognition domain is a chemoattractant for human neutrophils. Am J Physiol (1999) 0.92
Interaction of surfactant protein A with bacterial lipopolysaccharide may affect some biological functions. Am J Physiol (1995) 0.91
The ice-binding site of sea raven antifreeze protein is distinct from the carbohydrate-binding site of the homologous C-type lectin. Biochemistry (1998) 0.89
Characterization of chimeric lipopolysaccharides from Escherichia coli strain JM109 transformed with lipooligosaccharide synthesis genes (lsg) from Haemophilus influenzae. J Biol Chem (2000) 0.89
SPECTROPHOTOMETRIC DETERMINATION OF MICROGRAM QUANTITIES OF (ETHYLENEDINITRILO)TETRAACETIC ACID WITH BIS(2,4,6-TRIPYRIDYL-S-TRIAZINE)IRON(II). Anal Chem (1965) 0.85
Crystal structure of bitiscetin, a von Willebrand factor-dependent platelet aggregation inducer. Biochemistry (2001) 0.84
Deletion mapping of N-terminal domains of surfactant protein A. The N-terminal segment is required for phospholipid aggregation and specific inhibition of surfactant secretion. J Biol Chem (1999) 0.84
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med (2008) 9.64
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med (2005) 4.15
Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med (2002) 2.56
Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology (2011) 2.51
Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J Immunol (2002) 2.43
Diffuse cystic lung disease at high-resolution CT. AJR Am J Roentgenol (2011) 2.31
Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics (2002) 2.08
Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun (2004) 1.99
Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol (2002) 1.92
Lymphangioleiomyomatosis - a wolf in sheep's clothing. J Clin Invest (2012) 1.87
Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial. Lancet Respir Med (2013) 1.69
Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Invest (2010) 1.67
Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol (2003) 1.59
Cytotoxic necrotizing factor-1 contributes to Escherichia coli K1 invasion of the central nervous system. J Biol Chem (2002) 1.54
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest (2010) 1.52
Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest (2009) 1.50
67-kDa laminin receptor promotes internalization of cytotoxic necrotizing factor 1-expressing Escherichia coli K1 into human brain microvascular endothelial cells. J Biol Chem (2004) 1.48
Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans. Am J Respir Cell Mol Biol (2006) 1.47
Escherichia coli K1 RS218 interacts with human brain microvascular endothelial cells via type 1 fimbria bacteria in the fimbriated state. Infect Immun (2005) 1.41
Adhesive properties of Enterobacter sakazakii to human epithelial and brain microvascular endothelial cells. BMC Microbiol (2006) 1.38
Crystal structure of trimeric carbohydrate recognition and neck domains of surfactant protein A. J Biol Chem (2003) 1.37
The K1 capsule modulates trafficking of E. coli-containing vacuoles and enhances intracellular bacterial survival in human brain microvascular endothelial cells. Cell Microbiol (2003) 1.36
Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells. Mol Microbiol (2002) 1.33
Cloning and expression of the Escherichia coli K1 outer membrane protein A receptor, a gp96 homologue. Infect Immun (2003) 1.32
FimH-mediated Escherichia coli K1 invasion of human brain microvascular endothelial cells. Cell Microbiol (2007) 1.31
Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis. N Engl J Med (2008) 1.30
Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Chest (2006) 1.29
Current concepts on Escherichia coli K1 translocation of the blood-brain barrier. FEMS Immunol Med Microbiol (2004) 1.29
Alveolar surfactant protein D content modulates bleomycin-induced lung injury. Am J Respir Crit Care Med (2005) 1.28
Acanthamoeba interactions with human brain microvascular endothelial cells. Microb Pathog (2003) 1.28
Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J (2002) 1.28
African trypanosome interactions with an in vitro model of the human blood-brain barrier. J Parasitol (2004) 1.27
Air travel in women with lymphangioleiomyomatosis. Thorax (2006) 1.27
37-kDa laminin receptor precursor modulates cytotoxic necrotizing factor 1-mediated RhoA activation and bacterial uptake. J Biol Chem (2003) 1.26
Acanthamoeba castellanii induces host cell death via a phosphatidylinositol 3-kinase-dependent mechanism. Infect Immun (2005) 1.25
Binding of Candida albicans enolase to plasmin(ogen) results in enhanced invasion of human brain microvascular endothelial cells. J Med Microbiol (2003) 1.23
Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol (2002) 1.23
Pathogenesis of central nervous system tuberculosis. Curr Mol Med (2009) 1.22
Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment. Semin Respir Crit Care Med (2012) 1.20
Susceptibility of Hermansky-Pudlak mice to bleomycin-induced type II cell apoptosis and fibrosis. Am J Respir Cell Mol Biol (2007) 1.20
Outer membrane protein A and cytotoxic necrotizing factor-1 use diverse signaling mechanisms for Escherichia coli K1 invasion of human brain microvascular endothelial cells. Microb Pathog (2003) 1.19
Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis. Chest (2009) 1.19
Lung-restricted macrophage activation in the pearl mouse model of Hermansky-Pudlak syndrome. J Immunol (2006) 1.18
Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier. Infect Immun (2005) 1.17
Streptococcus agalactiae invasion of human brain microvascular endothelial cells is promoted by the laminin-binding protein Lmb. Microbes Infect (2007) 1.16
Escherichia coli interactions with Acanthamoeba: a symbiosis with environmental and clinical implications. J Med Microbiol (2006) 1.15
Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem (2003) 1.13
Comparative RNAi screening reveals host factors involved in enterovirus infection of polarized endothelial monolayers. Cell Host Microbe (2011) 1.13
CD46- and CD150-independent endothelial cell infection with wild-type measles viruses. J Gen Virol (2003) 1.12
Genomic comparison of Escherichia coli K1 strains isolated from the cerebrospinal fluid of patients with meningitis. Infect Immun (2006) 1.12
HbiF regulates type 1 fimbriation independently of FimB and FimE. Infect Immun (2006) 1.11
Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous system. J Infect Dis (2008) 1.11
Human astrocytes/astrocyte-conditioned medium and shear stress enhance the barrier properties of human brain microvascular endothelial cells. Brain Res (2007) 1.11
Pulmonary surfactant protein a inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity. J Immunol (2004) 1.11
Role of OmpA and IbeB in Escherichia coli K1 invasion of brain microvascular endothelial cells in vitro and in vivo. Pediatr Res (2002) 1.11
Pulmonary manifestations of Birt-Hogg-Dubé syndrome. Fam Cancer (2013) 1.10
Antimicrobial activity of native and synthetic surfactant protein B peptides. J Immunol (2006) 1.10
Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J (2002) 1.09
Differential Ca2+ signaling by thrombin and protease-activated receptor-1-activating peptide in human brain microvascular endothelial cells. Am J Physiol Cell Physiol (2003) 1.09
Interaction of Neisseria meningitidis with human brain microvascular endothelial cells: role of MAP- and tyrosine kinases in invasion and inflammatory cytokine release. Cell Microbiol (2004) 1.08
Impaired clearance of apoptotic cells from cystic fibrosis airways. Chest (2002) 1.07
Plasmodium falciparum uses gC1qR/HABP1/p32 as a receptor to bind to vascular endothelium and for platelet-mediated clumping. PLoS Pathog (2007) 1.06
Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo. Oncogene (2002) 1.06
Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infect Immun (2012) 1.06
The alveolar epithelium determines susceptibility to lung fibrosis in Hermansky-Pudlak syndrome. Am J Respir Crit Care Med (2012) 1.06
Lymphangioleiomyomatosis screening in women with tuberous sclerosis. Chest (2013) 1.05
Identification and characterization of Escherichia coli RS218-derived islands in the pathogenesis of E. coli meningitis. J Infect Dis (2006) 1.05
Cell-cell junctions of dermal microvascular endothelial cells contain tight and adherens junction proteins in spatial proximity. Biochemistry (2004) 1.04
Comparative signature-tagged mutagenesis identifies Pseudomonas factors conferring resistance to the pulmonary collectin SP-A. PLoS Pathog (2005) 1.03
Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein A. J Immunol (2004) 1.03
Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon. J Virol (2005) 1.03
Effects of ompA deletion on expression of type 1 fimbriae in Escherichia coli K1 strain RS218 and on the association of E. coli with human brain microvascular endothelial cells. Infect Immun (2006) 1.02
The capsule plays an important role in Escherichia coli K1 interactions with Acanthamoeba. Int J Parasitol (2006) 1.00
Retinoic acid-induced gene-1 (RIG-I) associates with the actin cytoskeleton via caspase activation and recruitment domain-dependent interactions. J Biol Chem (2009) 0.99
Modification of lipooligosaccharide with phosphoethanolamine by LptA in Neisseria meningitidis enhances meningococcal adhesion to human endothelial and epithelial cells. Infect Immun (2008) 0.99
Review: Structural determinants of pattern recognition by lung collectins. Innate Immun (2010) 0.99
Hcp family proteins secreted via the type VI secretion system coordinately regulate Escherichia coli K1 interaction with human brain microvascular endothelial cells. Infect Immun (2011) 0.98
Correction of pulmonary abnormalities in Sftpd-/- mice requires the collagenous domain of surfactant protein D. J Biol Chem (2006) 0.98
The resident scholar program: a research training opportunity for internal medicine house staff. J Cancer Educ (2007) 0.98
Calcineurin inhibitor-induced headache: clinical characteristics and possible mechanisms. Headache (2005) 0.97
Haemophilus influenzae Rd KW20 has virulence properties. J Med Microbiol (2003) 0.97
The type III secretion system is involved in the invasion and intracellular survival of Escherichia coli K1 in human brain microvascular endothelial cells. FEMS Microbiol Lett (2009) 0.96
Pertussis toxin transiently affects barrier integrity, organelle organization and transmigration of monocytes in a human brain microvascular endothelial cell barrier model. Cell Microbiol (2006) 0.96
Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophages. J Biol Chem (2011) 0.95
A case of metastatic renal cell carcinoma to thyroid gland. Chonnam Med J (2011) 0.94
Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis. J Neurovirol (2006) 0.94
Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages. J Biol Chem (2002) 0.94
The flagellum of Pseudomonas aeruginosa is required for resistance to clearance by surfactant protein A. PLoS One (2007) 0.94
Surfactant protein A is a principal and oxidation-sensitive microbial permeabilizing factor in the alveolar lining fluid. J Biol Chem (2005) 0.94
NlpI contributes to Escherichia coli K1 strain RS218 interaction with human brain microvascular endothelial cells. Infect Immun (2010) 0.93
Bacillus anthracis protease InhA increases blood-brain barrier permeability and contributes to cerebral hemorrhages. PLoS One (2011) 0.93
Approaches to bacterial RNA isolation and purification for microarray analysis of Escherichia coli K1 interaction with human brain microvascular endothelial cells. J Clin Microbiol (2005) 0.92
Complete genome sequence of the neonatal-meningitis-associated Escherichia coli strain CE10. J Bacteriol (2011) 0.92
Invasion processes of pathogenic Escherichia coli. Int J Med Microbiol (2005) 0.92
Birt-Hogg-Dubé syndrome. Fam Cancer (2013) 0.91
Mutagenesis of surfactant protein D informed by evolution and x-ray crystallography enhances defenses against influenza A virus in vivo. J Biol Chem (2011) 0.91
Arachidonic acid metabolism regulates Escherichia coli penetration of the blood-brain barrier. Infect Immun (2010) 0.90
Cryptococcus neoformans phospholipase B1 activates host cell Rac1 for traversal across the blood-brain barrier. Cell Microbiol (2012) 0.90
Outer membrane protein A (OmpA) of Cronobacter sakazakii binds fibronectin and contributes to invasion of human brain microvascular endothelial cells. Foodborne Pathog Dis (2009) 0.90